# Impact of Androgen Signaling on the Composition of the Immune Microenvironment in Glioblastomas

> **NCT07472387** · NA · NOT_YET_RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 40 (estimated)

## Conditions studied

- Glioblastoma (GBM)

## Interventions

- **OTHER:** blood sampling
- **OTHER:** saliva sampling
- **OTHER:** stool sampling
- **OTHER:** Tumor sampling

## Key facts

- **NCT ID:** NCT07472387
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2030-04-01
- **Final completion:** 2030-04-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07472387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07472387, "Impact of Androgen Signaling on the Composition of the Immune Microenvironment in Glioblastomas". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07472387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*